![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Drug-Drug Interaction Profile of Sofosbuvir/Velpatasvir Fixed-Dose Combination
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Erik Mogalian, Gong Shen, Lisa Moorehead, Karim Sajwani, John McNally, John Ling, Anita Mathias
Gilead Sciences, Inc., Foster City, California, USA
![EASL1](../images/042116/042116-3/EASL1.gif)
![EASL2](../images/042116/042116-3/EASL2.gif)
![EASL3](../images/042116/042116-3/EASL3.gif)
![EASL4](../images/042116/042116-3/EASL4.gif)
![EASL5](../images/042116/042116-3/EASL5.gif)
![EASL6](../images/042116/042116-3/EASL6.gif)
![EASL7](../images/042116/042116-3/EASL7.gif)
![EASL8](../images/042116/042116-3/EASL8.gif)
![EASL9](../images/042116/042116-3/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|